首页> Discover oncology> Exploring the role of 338 cerebrospinal fluid metabolites in primary brain malignancies risk: a Mendelian randomization study.

Exploring the role of 338 cerebrospinal fluid metabolites in primary brain malignancies risk: a Mendelian randomization study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hengqiu,He

第一单位： Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, No. 288 Tianwen Road, Nan'an District, Chongqing, 400010, China.;Chongqing Key Laboratory of Immunotherapy, Chongqing, 400037, China.

作者： Hengqiu,He ^[1] ; Rongxin,Liao ^[1] ; Xue,Wu ^[1] ; Fanghao,Cai ^[1] ; Rui,Kong ^[1] ; Xiaoyue,Zhang ^[1] ; Zaicheng,Xu ^[1] ; Zhenzhou,Yang ^[2] ; Yuan,Peng ^[3]

作者单位： Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, No. 288 Tianwen Road, Nan'an District, Chongqing, 400010, China.;Chongqing Key Laboratory of Immunotherapy, Chongqing, 400037, China. ^[1] Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, No. 288 Tianwen Road, Nan'an District, Chongqing, 400010, China. yangzz@cqmu.edu.cn.;Chongqing Key Laboratory of Immunotherapy, Chongqing, 400037, China. yangzz@cqmu.edu.cn. ^[2] Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, No. 288 Tianwen Road, Nan'an District, Chongqing, 400010, China. pengyuan1127@cqmu.edu.cn.;Chongqing Key Laboratory of Immunotherapy, Chongqing, 400037, China. pengyuan1127@cqmu.edu.cn. ^[3]

关键词 5-methylthioadenosine Cerebrospinal fluid metabolites Mendelian randomization Primary brain malignancy

DOI 10.1007/s12672-025-04111-9

PMID 41263901

发布时间 2026-01-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Discover oncology

2025年16卷1期

2249页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Discover oncology

2025年16卷1期

2249页

检索历史清除

Exploring the role of 338 cerebrospinal fluid metabolites in primary brain malignancies risk: a Mendelian randomization study.

Discover oncology

相似文献

同项目论文

Discover oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Exploring the role of 338 cerebrospinal fluid metabolites in primary brain malignancies risk: a Mendelian randomization study.

Discover oncology

相似文献

同项目论文

Discover oncology

相关期刊

检索历史清除